RABEEDON-L Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
RABEEDON-L
Rabeprazole (Enteric Coated) 20mg + Levosulpiride 5mg SR
RABEEDON-L is an advanced gastro-protective formulation developed for the rapid healing of mucosal erosion, acid peptic disorders, and gastroesophageal reflux disease (GERD).
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
Forms a polyanionic protective barrier coating over inflamed gastric ulcers, preventing enzymatic acid degradation while facilitating tissue re-epithelialization.
Administer on an empty stomach 1 hour before principal meals, or as posology prescribed by the gastroenterologist.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
RABEEDON-L features Rabeprazole (Enteric Coated) 20mg + Levosulpiride 5mg SR prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Apply for Exclusive Marketing Rights of RABEEDON-L
Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.
Questions Regarding RABEEDON-L
What is the therapeutic indication and composition of RABEEDON-L?
RABEEDON-L contains Rabeprazole (Enteric Coated) 20mg + Levosulpiride 5mg SR indicated for Peptic Ulcer Disease as formulated by Sygnus Biotech.
What packaging presentations are available for RABEEDON-L?
RABEEDON-L is supplied in tamper-evident 10 x 10 Blister Pack / 30 Softgels Bottle, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for RABEEDON-L?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for RABEEDON-L along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
RABEEDON-L is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Capsules & Softgel
View all Capsules & Softgel →
CEEVIT-Q10
CO-Enzyme Q10 , Lycopene , L-Arginine , Wheat-Germ oil , Omega-3 Fatty Acid(EPA & DHA) , Piperine , Caroteniods , Vitamins & Minerals,
SBCOFF SOFTGEL
Dextromethorphan Hydrobromide 10mg + Chlorpheniramine Maleate 2mg + Phenylephrine Hydrochloride 5mg
GROVITA-E-400 SOFTGEL
Vitamin E 400mg Softgel Capsule